• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

锝-99m标记的单克隆抗体在转移性黑色素瘤检测中的应用

Technetium-99m labeled monoclonal antibodies in the detection of metastatic melanoma.

作者信息

Serafini A N, Kotler J, Feun L, Dewanjee M, Robinson D, Salk D, Sfakianakis G, Abrams P, Savaraj N, Goodwin D

机构信息

Department of Radiology, University of Miami School of Medicine, Florida.

出版信息

Clin Nucl Med. 1989 Aug;14(8):580-7. doi: 10.1097/00003072-198908000-00006.

DOI:10.1097/00003072-198908000-00006
PMID:2805539
Abstract

Twenty-six stage II/III malignant melanoma patients with 321 measurable metastatic lesions were imaged using Fab fragments of an IgG murine monoclonal antibody labeled specifically with 10-30 mCi Tc-99m with a bi-functional chelating method (NeoRx, Seattle, WA). There were no side effects or adverse reactions. Immunoscintigraphy demonstrated 66.6% of lesions larger than 1 cm and 92.5% of lesions larger than 3 cm. Most frequently detected metastases were in lymph nodes, subcutaneous areas, and bone. Of lesions less than 1 cm, 23.6% were detected if superficial cutaneous lesions were excluded. The smallest detectable lesion was 4 mm. Twenty-one additional clinically unsuspected sites were visualized in 12 of the 26 patients studied. Of these, 56% were confirmed as metastasis by other tests. There were apparent nonspecific localizations owing to other causes, including fracture, varicosities, skin abscess and pneumonitis. Increased experience in image analysis facilitates correct interpretation of these localizations. This study demonstrates that imaging with Tc-99m labeled antibody fragments detects melanoma lesions in organs routinely surveyed and in other areas not routinely assessed by other imaging techniques. The procedure is readily performed and safe. The principal advantage of the test is its ability to survey the entire body and all organs with a single test. Its principal limitation, in common with other diagnostic imaging procedures, is its poor sensitivity for detecting lesions less than 1 cm.

摘要

26例II/III期恶性黑色素瘤患者,共321个可测量的转移病灶,采用双功能螯合法,用10 - 30毫居里的Tc - 99m特异性标记的IgG鼠单克隆抗体的Fab片段进行成像(NeoRx,华盛顿州西雅图)。未出现副作用或不良反应。免疫闪烁显像显示,直径大于1厘米的病灶检出率为66.6%,直径大于3厘米的病灶检出率为92.5%。最常检测到转移的部位是淋巴结、皮下区域和骨骼。对于直径小于1厘米的病灶,若排除浅表皮肤病灶,检出率为23.6%。最小可检测病灶为4毫米。在研究的26例患者中,有12例发现了另外21个临床未怀疑的部位。其中,56%经其他检查确认为转移灶。还存在因其他原因导致的明显非特异性定位,包括骨折、静脉曲张、皮肤脓肿和肺炎。图像分析经验的增加有助于对这些定位进行正确解读。本研究表明,用Tc - 99m标记的抗体片段成像可检测常规检查器官及其他成像技术未常规评估区域的黑色素瘤病灶。该操作简便且安全。该检测的主要优点是一次检测就能对全身和所有器官进行检查。与其他诊断成像程序一样,其主要局限性是对直径小于1厘米的病灶检测灵敏度较低。

相似文献

1
Technetium-99m labeled monoclonal antibodies in the detection of metastatic melanoma.锝-99m标记的单克隆抗体在转移性黑色素瘤检测中的应用
Clin Nucl Med. 1989 Aug;14(8):580-7. doi: 10.1097/00003072-198908000-00006.
2
Successful imaging of malignant melanoma with technetium-99m-labeled monoclonal antibodies.用锝-99m标记的单克隆抗体对恶性黑色素瘤进行成功成像。
J Nucl Med. 1989 Jan;30(1):25-32.
3
A technetium-labeled monoclonal antibody for imaging metastatic melanoma.一种用于成像转移性黑色素瘤的锝标记单克隆抗体。
Am J Clin Oncol. 1991 Apr;14(2):156-61. doi: 10.1097/00000421-199104000-00012.
4
[Immunoscintigraphy with a technetium 99m-labeled monoclonal antibody in patients with melanoma].99m锝标记单克隆抗体免疫闪烁成像在黑色素瘤患者中的应用
Wien Klin Wochenschr. 1987 Apr 3;99(7):232-9.
5
Multicenter study of immunoscintigraphy with radiolabeled monoclonal antibodies in patients with melanoma.
Cancer Res. 1986 Sep;46(9):4817-22.
6
Radioimaging of melanoma using 99mTc-labeled Fab fragment reactive with a high molecular weight melanoma antigen.使用与高分子量黑色素瘤抗原反应的99mTc标记的Fab片段对黑色素瘤进行放射性成像。
Cancer Res. 1990 Feb 1;50(3 Suppl):904s-908s.
7
Monoclonal antibody imaging of human melanoma. Radioimmunodetection by subcutaneous or systemic injection.人黑色素瘤的单克隆抗体成像。通过皮下或全身注射进行放射免疫检测。
Ann Surg. 1986 Sep;204(3):223-35. doi: 10.1097/00000658-198609000-00002.
8
Anti-melanoma antibodies bind preferentially to diploid metastases in immunoscintigraphy.抗黑色素瘤抗体在免疫闪烁显像中优先结合二倍体转移灶。
Nucl Med Commun. 1990 Sep;11(9):597-605. doi: 10.1097/00006231-199009000-00003.
9
[Immunoscintigraphy with 99mTc marked melanoma antibody in patients with malignant melanoma].99mTc标记的黑色素瘤抗体在恶性黑色素瘤患者中的免疫闪烁显像
Helv Chir Acta. 1989 Jun;56(1-2):11-3.
10
Clinical experience with Tc-99m labeled (N2S2) anti-melanoma antibody fragments and single photon emission computed tomography.锝-99m标记的(N2S2)抗黑色素瘤抗体片段及单光子发射计算机断层扫描的临床经验
Am J Physiol Imaging. 1992 Apr-Jun;7(2):48-58.

引用本文的文献

1
Radiopharmaceuticals: state of the art.放射性药物:最新技术水平
Eur J Nucl Med. 1990;17(6-8):346-64. doi: 10.1007/BF01268027.